Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
June 10, 2024 07:32 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Inotiv, Inc. Provides Business Updates
June 10, 2024 07:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
FuelCell Energy Reports Second Quarter of Fiscal 2024 Results
June 10, 2024 07:30 ET
|
FuelCell Energy, Inc.
Second Quarter Fiscal 2024 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $22.4 million, compared to $38.3 millionGross loss of $(7.1) million compared...
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
June 10, 2024 07:30 ET
|
Shattuck Labs, Inc.
AUSTIN, TX and DURHAM, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion...
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
June 10, 2024 07:30 ET
|
Revive Therapeutics Ltd.
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 10, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases...
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression
June 10, 2024 07:30 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, June 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
Orezone Announces Sean Harvey as Board Chair and Results of Annual and Special Meeting of Shareholders
June 10, 2024 07:30 ET
|
Orezone Gold Corporation
VANCOUVER, British Columbia, June 10, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) reports that all resolutions from the Company’s annual...
VitalHub Corp. Announces Acquisition of Premier I.T. Partnership Limited
June 10, 2024 07:30 ET
|
VitalHub Corp.
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Premier I.T....
TRANSFER OF HARVIA’S OWN SHARES AS REWARDS UNDER THE INCENTIVE PROGRAM
June 10, 2024 07:30 ET
|
Harvia Oyj
HARVIA PLC STOCK EXCHANGE RELEASE JUNE 10, 2024 AT 14:30 The Board of Directors of Harvia Plc has on 6 June 2024 decided on a directed share issue...